Skip to main content
Caplight Logo









Standigm

Standigm

Private
SeoulHealthcare & Life Scienceshttps://standigm.com/

Last Round

Series C

Extension

Jul 2, 2021

Est. Valuation

$200M

Total Funding Raised

$92.13M

Company Overview

Standigm is a biotechnology company that provides an AI-based platform for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

drug discoveryai drug discoveryin silico drug discoverylead optimizationtarget discoverydrug repurposingadmetpharmaceutical aibiotech aigenerative chemistryai saascontract research organizationcrosmall molecule designcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Standigm Comparables

Compare Standigm with similar companies based on industry and business-model similarity.

Standigm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmCADD Co., Ltd.
88%
Iktos
86%
Arontier
79%

Standigm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJul 2, 2021
StrategicJul 1, 2021
Series CMar 5, 2021
StrategicNov 18, 2019
Series BMar 4, 2019
Series A
Aug 1, 2016

Key People

Founding team and executive leadership

Sang Ok Song

Chief Executive Officer, Chief Technology Officer, Chief Scientific Officer, Co-founder and COO, Chief Transformation Officer & Co-founder

Founding Team

YounSung Choo

Chief Executive Officer

Executive Team

InSuk Joung

Chief Technology Officer

Executive Team

Standigm Investors

Notable investors and investment history

Standigm investors
InvestorRounds
InterVestSeries C
DSC InvestmentSeries C, Series B
Kakao VenturesSeries A, Series C, Seed, Series B
Tantan Global PartnersSeries C
SK Inc.Strategic
Wonik Investment PartnersSeries C, Series B
Pavilion CapitalSeries C, Series C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors grew 381% MoM, reaching 3.6K.

  • Nov 18, 2019

    $7.2M round led by SK Inc.

Standigm Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Standigm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Standigm's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range25
Year Founded2015
Last FundingJul 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?